Pfizer Withdraws Anti-Smoking Drug Due To Carcinogenicity

Pfizer Withdraws Anti-Smoking Drug Due To Carcinogenicity

Photo: Getty

Pfizer’s drug turned out to be dangerous

The company recommended continuing to take the prescription drug, and then refer to the attending physician to replace it with another drug.

The American company Pfizer has withdrawn from sale all stocks of the anti-smoking drug Chantix (called Champix in Europe) after it revealed chemicals that can cause cancer, Reuters reported, citing the company’s press service on September 19.

The agency notes that Pfizer stopped supplying the drug in June and asked distributors for the drug to stop selling.

At the same time, the company assured that there is no risk of an early development of the disease in patients. There she recommended to continue taking the prescription drug, and then turn to the attending physician to replace it with another medicine.

Scientists have warned of the dangers of hot tea

The drug was approved by the US FDA in 2006. It is prescribed for persons 18 years of age and older to help in the fight against smoking. Typically, patients take the drug for 12 to 24 weeks.

Earlier, a team of scientists from the Federal University of São Paulo found out what type and intensity of physical activity reduces the risk of cancer by a third.

News from Perild.com in Telegram. Subscribe to our channel

.

Leave a Reply

Your email address will not be published.